The EU Biotech Act was first spoken about in EC President Ursula von der Leyen's political guidelines for 2025 in July 2024.

In 2023, the global biotechnology market size was estimated at $1.55 trillion. This number is projected to reach $3.88 trillion by 2030, representing an anticipated CAGR of 13.96% from 2024 to 2030, ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

In this article, we will look at the 10 Most Profitable Biotech Stocks to Invest in Now. Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s ‘Power Lunch’ on March 5 to talk about ...

Without more capital, Europe’s scientific leadership will not translate into industrial strength, warns Jérôme Van Biervliet ...

With that as a backdrop, let's consider two companies in the biotech industry that could make steady progress in the next few ...

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have been among the most active investors in biotech startups this year.

Learn more about whether Legend Biotech Corporation or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.

Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo!

Biotech investors have not often looked at a balding head of hair and been struck with inspiration, even on the rare ...

Governor Kathy Hochul announced Thursday that Regeneron Pharmaceuticals, a global leader in biotechnology founded in New York State, will create 1,000 new jobs ...